U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 26025

  • Showing results for cure phthisis. Your search for corephthisis retrieved no results.
1.
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Cochrane Database Syst Rev. 2022; 2022(5): CD014841. Published online 2022 May 18. doi: 10.1002/14651858.CD014841.pub2
PMCID:
PMC9115865
ArticlePDF–1.9M
2.
Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
Cochrane Database Syst Rev. 2021; 2021(3): CD013694. Published online 2021 Mar 23. doi: 10.1002/14651858.CD013694.pub2
PMCID:
PMC8437892
ArticlePDF–1024K
3.
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid, Susan E. Dorman, Narges Alipanah, Pennan M. Barry, Jan L. Brozek, Adithya Cattamanchi, Lelia H. Chaisson, Richard E. Chaisson, Charles L. Daley, Malgosia Grzemska, Julie M. Higashi, Christine S. Ho, Philip C. Hopewell, Salmaan A. Keshavjee, Christian Lienhardt, Richard Menzies, Cynthia Merrifield, Masahiro Narita, Rick O'Brien, Charles A. Peloquin, Ann Raftery, Jussi Saukkonen, H. Simon Schaaf, Giovanni Sotgiu, Jeffrey R. Starke, Giovanni Battista Migliori, Andrew Vernon
Clin Infect Dis. 2016 Oct 1; 63(7): e147–e195. Published online 2016 Aug 10. doi: 10.1093/cid/ciw376
PMCID:
PMC6590850
ArticlePDF–999K
4.
Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis
Chuan-Jun Xu, Pu-Xuan Lu, Chun-Hua Li, Yu-Lin He, Wei-Jun Fang, Ru-Ming Xie, Guan-Qiao Jin, Yi-Bo Lu, Qiu-Ting Zheng, Guang-Ping Zheng, Sheng-Xiu Lv, Hua Huang, Li Li, Meiji Ren, Yu-Xin Shi, Xin-Nian Wen, Lin Li, Fang-Jun Wei, Dai-Lun Hou, Yan Lv, Fei Shan, Zheng-Can Wu, Zhi-Liang Hu, Xiang-Rong Zhang, Du-Xian Liu, Wei-Ya Shi, Hui-Ru Li, Na Zhang, Min Song, Xin Zhang, Ying-Ying Deng, Jinlong Li, Qiang Liu, Dechun Li, Lingling Zhao, Bu-Dong Chen, Yan-Bin Shi, Feng-Li Jiang, Xin Tang, Li-Ji Wu, Wei Ma, Xin-Yue Xu, Hong-Jun Li
Quant Imaging Med Surg. 2024 Jan 3; 14(1): 1039–1060. Published online 2023 Oct 25. doi: 10.21037/qims-23-1223
PMCID:
PMC10784038
ArticlePDF–4.3M
5.
Study on the awareness and its influencing factors of patients with pulmonary tuberculosis on preferential policies for tuberculosis prevention and treatment in Shandong, China
Jin Jin, Hong Geng, Yuan Li, Maoshui Wang, Shulin Yang, Xiuli Bi, Wuwei Tao
Medicine (Baltimore) 2022 Nov 18; 101(46): e31640. Published online 2022 Nov 18. doi: 10.1097/MD.0000000000031640
PMCID:
PMC9678548
ArticlePDF–456K
6.
Symptom‐ and chest‐radiography screening for active pulmonary tuberculosis in HIV‐negative adults and adults with unknown HIV status
Cochrane Database Syst Rev. 2022; 2022(3): CD010890. Published online 2022 Mar 23. doi: 10.1002/14651858.CD010890.pub2
PMCID:
PMC9109771
ArticlePDF–2.6M
7.
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
David J Horne, Mikashmi Kohli, Jerry S Zifodya, Ian Schiller, Nandini Dendukuri, Deanna Tollefson, Samuel G Schumacher, Eleanor A Ochodo, Madhukar Pai, Karen R Steingart
Cochrane Database Syst Rev. 2019; 2019(6): CD009593. Published online 2019 Jun 7. doi: 10.1002/14651858.CD009593.pub4
PMCID:
PMC6555588
ArticlePDF–2.8M
8.
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: study protocol for TBTC Study 31/ACTG A5349 phase 3 clinical trial
Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova, Stefan V. Goldberg, Lorna Bozeman, William J. Burman, Kwok-Chiu Chang, Michael Chen, Mark Cotton, Kelly E. Dooley, Melissa Engle, Pei-Jean Feng, Courtney V. Fletcher, Phan Ha, Charles M. Heilig, John L. Johnson, Erica Lessem, Beverly Metchock, Jose M. Miro, Nguyen Viet Nhung, April C. Pettit, Patrick P.J. Phillips, Anthony T. Podany, Anne E. Purfield, Kathleen Robergeau, Wadzanai Samaneka, Nigel A. Scott, Erin Sizemore, Andrew Vernon, Marc Weiner, Susan Swindells, Richard E. Chaisson, The AIDS Clinical Trials Group and the Tuberculosis Trials Consortium
Contemp Clin Trials. Author manuscript; available in PMC 2021 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2020 Mar; 90: 105938. Published online 2020 Jan 22. doi: 10.1016/j.cct.2020.105938
PMCID:
PMC7307310
ArticlePDF–293K
9.
Characterization of antibody response against 16kD and 38kD of M. tuberculosis in the assisted diagnosis of active pulmonary tuberculosis
Xiaohui Hao, Jie Bai, Yingying Ding, Jinhong Wang, Yidian Liu, Lan Yao, Wei Pan
Ann Transl Med. 2020 Aug; 8(15): 945. doi: 10.21037/atm-20-5476
PMCID:
PMC7475385
ArticlePDF–430K
10.
Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
Angeline G Grace, Abhenil Mittal, Siddharth Jain, Jaya P Tripathy, Srinath Satyanarayana, Prathap Tharyan, Richard Kirubakaran, Cochrane Infectious Diseases Group
Cochrane Database Syst Rev. 2019; 2019(12): CD012918. Published online 2019 Dec 12. doi: 10.1002/14651858.CD012918.pub2
PMCID:
PMC6953336
ArticlePDF–926K
11.
Trends and Projection of the Incidence of Active Pulmonary Tuberculosis in Southwestern China: Age-Period-Cohort Analysis
Jinou Chen, Yubing Qiu, Wei Wu, Rui Yang, Ling Li, Yunbin Yang, Xing Yang, Lin Xu
JMIR Public Health Surveill. 2023; 9: e48015. Published online 2023 Dec 29. doi: 10.2196/48015
PMCID:
PMC10787335
Article
12.
New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review
Fuzhen Zhang, Fan Zhang, Yu Dong, Liang Li, Yu Pang
Infect Dis Ther. 2023 Dec; 12(12): 2665–2689. Published online 2023 Nov 8. doi: 10.1007/s40121-023-00887-x
PMCID:
PMC10746651
ArticlePDF–666K
13.
Epidemiological characteristics of pulmonary tuberculosis among students in Guizhou, China: a retrospective study from 2010 to 2020
Jian Zhou, Xiaoxue Ma, Ting-Jia Lu, Yan Zhuang, Jin-Lan Li, Huijuan Chen
BMJ Open. 2023; 13(5): e072010. Published online 2023 May 17. doi: 10.1136/bmjopen-2023-072010
PMCID:
PMC10193094
ArticlePDF–3.0M
14.
Health-related quality of life after pulmonary tuberculosis in South Korea: analysis from the Korea National Health and Nutrition Examination Survey between 2010 and 2018
Sang Hyuk Kim, Hyun Lee, Youlim Kim
Health Qual Life Outcomes. 2021; 19: 195. Published online 2021 Aug 9. doi: 10.1186/s12955-021-01833-6
PMCID:
PMC8350551
ArticlePDF–949K
15.
Clinical, laboratory, and radiographic aspects of patients with pulmonary tuberculosis and dysglycemia and tuberculosis treatment outcomes
André Luiz Bezerra, Adriana da Silva Rezende Moreira, Lorrayne Isidoro-Gonçalves, Carla F. dos Santos Lara, Gustavo Amorim, Elisangela C. Silva, Afrânio Lineu Kritski, Anna Cristina C. Carvalho
J Bras Pneumol. 2022; 48(6): e20210505. Published online 2022 Nov 11. doi: 10.36416/1806-3756/e20210505
PMCID:
PMC9747138
ArticlePDF–380K
16.
Epidemiological characteristics of pulmonary tuberculosis in mainland China from 2004 to 2015: a model-based analysis
Zuiyuan Guo, Dan Xiao, Xiuhong Wang, Yayu Wang, Tiecheng Yan
BMC Public Health. 2019; 19: 219. Published online 2019 Feb 21. doi: 10.1186/s12889-019-6544-4
PMCID:
PMC6383277
ArticlePDF–2.9M
17.
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid, Susan E Dorman, Narges Alipanah, Pennan M Barry, Jan L Brozek, Adithya Cattamanchi, Lelia H Chaisson, Richard E Chaisson, Charles L Daley, Malgosia Grzemska, Julie M Higashi, Christine S Ho, Philip C Hopewell, Salmaan A Keshavjee, Christian Lienhardt, Richard Menzies, Cynthia Merrifield, Masahiro Narita, Rick O'Brien, Charles A Peloquin, Ann Raftery, Jussi Saukkonen, H Simon Schaaf, Giovanni Sotgiu, Jeffrey R Starke, Giovanni Battista Migliori, Andrew Vernon
Clin Infect Dis. 2016 Oct 1; 63(7): 853–867. Published online 2016 Sep 1. doi: 10.1093/cid/ciw566
PMCID:
PMC6366011
ArticlePDF–460K
18.
Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Shashikant Srivastava, Paula Bendet, Thearith Koeuth, Sujata M Bhavnani, Paul G Ambrose, Wynand Smythe, Helen McIlleron, Guy Thwaites, Mourad Gumusboga, Armand Van Deun, Tawanda Gumbo
Clin Infect Dis. 2018 Dec 15; 67(Suppl 3): S274–S283. Published online 2018 Nov 28. doi: 10.1093/cid/ciy618
PMCID:
PMC6904296
ArticlePDF–843K
19.
Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis
Anna Ritah Namuganga, Novel N. Chegou, Harriet Mayanja-Kizza
Front Med (Lausanne) 2021; 8: 709793. Published online 2021 Sep 23. doi: 10.3389/fmed.2021.709793
PMCID:
PMC8495065
ArticlePDF–1.1M
20.
Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis
Hyung-Jun Kim, Ye Jin Lee, Myung Jin Song, Byoung Soo Kwon, Yeon Wook Kim, Sung Yoon Lim, Yeon-Joo Lee, Jong Sun Park, Young-Jae Cho, Choon-Taek Lee, Jae Ho Lee
Sci Rep. 2023; 13: 11275. Published online 2023 Jul 12. doi: 10.1038/s41598-023-38394-1
PMCID:
PMC10338469
ArticlePDF–1.4M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center